Goodwill of Cytek Biosciences, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Cytek Biosciences, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Cytek Biosciences, Inc. Goodwill for the quarter ending 30 Sep 2025 was $16,698,000, a 3.2% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Cytek Biosciences, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $16,698,000 +$515,000 +3.2% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $16,707,000 +$524,000 +3.2% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $16,678,000 +$495,000 +3.1% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $16,663,000 +$480,000 +3% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $16,183,000 -$274,000 -1.7% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $16,183,000 -$2,960,000 -15% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $16,183,000 -$2,960,000 -15% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $16,183,000 +$6,039,000 +60% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $16,457,000 +$6,313,000 +62% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $19,143,000 +$8,999,000 +89% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $19,143,000 +$8,999,000 +89% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $10,144,000 $0 0% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $10,144,000 +$9,668,000 +2031% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $10,144,000 +$9,668,000 +2031% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $10,144,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $10,144,000 +$9,668,000 +2031% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $476,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $476,000 30 Jun 2021 10-Q 03 Sep 2021 2021 Q2
Q4 2020 $476,000 31 Dec 2020 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.